ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
53709.1 IP-LS
Projekttitel
AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections
Projekttitel Englisch
AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
-

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections
Kurzbeschreibung
(Englisch)
AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections
Abstract
(Deutsch)
The consortium will develop AlvireX - a novel drug screening platform that will accelerate and improve drug development for respiratory viruses, such as SARS-CoV-2. Here, we will deliver the first AlvireX kit tailored to COVID-19 research, which will be ready to enter the market in Q1 2023.